William Blair Lowers Earnings Estimates for agilon health

agilon health, inc. (NYSE:AGL) – Equities researchers at William Blair lowered their Q1 2025 earnings estimates for shares of agilon health in a research note issued to investors on Tuesday, February 25th. William Blair analyst R. Daniels now anticipates that the company will post earnings per share of $0.00 for the quarter, down from their previous forecast of $0.05. William Blair currently has a “Market Perform” rating on the stock. The consensus estimate for agilon health’s current full-year earnings is ($0.59) per share. William Blair also issued estimates for agilon health’s Q1 2026 earnings at $0.05 EPS, Q2 2026 earnings at ($0.02) EPS, Q3 2026 earnings at ($0.08) EPS and Q4 2026 earnings at ($0.13) EPS.

Several other research firms have also recently commented on AGL. Citigroup raised shares of agilon health from a “sell” rating to a “neutral” rating and lifted their target price for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. JMP Securities cut shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Sanford C. Bernstein raised their price target on shares of agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a research note on Wednesday, January 15th. TD Cowen decreased their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research note on Monday, November 11th. Finally, Macquarie assumed coverage on shares of agilon health in a research note on Monday, December 16th. They set a “neutral” rating and a $3.00 price target for the company. Two analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $3.95.

agilon health Price Performance

agilon health stock opened at $3.12 on Thursday. agilon health has a 52 week low of $1.50 and a 52 week high of $7.73. The company’s 50 day moving average price is $2.96 and its two-hundred day moving average price is $3.03. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock has a market cap of $1.29 billion, a P/E ratio of -3.32 and a beta of 0.66.

Insider Buying and Selling at agilon health

In other news, Director Karen Mcloughlin purchased 25,000 shares of the firm’s stock in a transaction dated Friday, December 13th. The shares were purchased at an average price of $2.20 per share, with a total value of $55,000.00. Following the completion of the acquisition, the director now owns 73,166 shares in the company, valued at $160,965.20. This trade represents a 51.90 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director John William Wulf purchased 45,000 shares of the firm’s stock in a transaction dated Thursday, December 5th. The stock was purchased at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now owns 206,133 shares of the company’s stock, valued at approximately $449,369.94. This trade represents a 27.93 % increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 77,500 shares of company stock valued at $169,600 in the last 90 days. 3.20% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. Captrust Financial Advisors increased its holdings in shares of agilon health by 10.9% in the fourth quarter. Captrust Financial Advisors now owns 35,485 shares of the company’s stock worth $67,000 after purchasing an additional 3,494 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of agilon health by 2.5% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 206,991 shares of the company’s stock worth $393,000 after purchasing an additional 5,107 shares during the period. MetLife Investment Management LLC increased its holdings in shares of agilon health by 4.0% in the fourth quarter. MetLife Investment Management LLC now owns 174,551 shares of the company’s stock worth $332,000 after purchasing an additional 6,762 shares during the period. Symphony Financial Services Inc. increased its holdings in shares of agilon health by 44.3% in the fourth quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company’s stock worth $44,000 after purchasing an additional 7,058 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new position in agilon health in the third quarter worth $28,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.